Press releases

Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Tuesday, September 30, 2025.

MARLBOROUGH, Mass., Aug. 6, 2025 – Boston Scientific Corporation (NYSE: BSX) today announced data from a recent national survey of 2,000 U.S. women between the ages of 30 and 65, which examined...

"This was another excellent quarter, marked by exceptional top-line performance,” said chairman and CEO Mike Mahoney

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2025, on Wednesday, July 23,...

Boston Scientific will participate in two upcoming investor conferences in May 2025. A live webcast and replay will be available for each event. Read more.

Trial achieves positive results in the treatment of persistent atrial fibrillation.

After 30 successful years with Boston Scientific, Dan will work closely with CFO successor Jon Monson to ensure a smooth transition.

"We delivered an exceptional quarter to start the year,” said Mike Mahoney, chairman and CEO, Boston Scientific.

Boston Scientific will webcast its conference call with financial results and business highlights for Q1 ended March 31, 2025. Learn how to tune in.